Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-006 · Missing data
HG-MISS-01: Information needed to classify
Information needed to classify. Evaluates low testosterone confirmed or single.
Condition
- low testosterone confirmed or single
- LH, FSH, prolactin or SHBG missing
What it reports
- The type of hypogonadism cannot be classified without gonadotropins and prolactin
Diagnostic boundary
- Names what is needed.
Evidence
- EV-ES-TRT-2018Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.Supports: Diagnose with symptoms plus unequivocally low testosterone on two morning fasting samples Contraindications and cautions to therapy; monitoring of hematocrit and PSA Evaluation of the type of hypogonadism with LH and FSH
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
TESTO-FX-02
One low testosterone
Total testosterone 218 ng/dL on a single morning sample.
TESTO-FX-05
Raised prolactin with low testosterone
Prolactin 95 ng/mL.
TESTO-FX-06
Headache, visual field loss and prolactin 310
Possible pituitary mass effect.
TESTO-FX-09
Afternoon sample
Testosterone 240 drawn at 3 pm.
TESTO-FX-10
Two low values during acute illness
Both samples were drawn while the patient was in hospital.
TESTO-FX-19
Confirmed low, gonadotropins missing
The type of hypogonadism cannot be classified yet.
TESTO-FX-20
Two samples that disagree
280 ng/dL, then 410 ng/dL.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.